LENZ
Lenz Therapeutics Inc
NASDAQ · Pharmaceuticals
$14.22
+0.25 (+1.79%)
Open$14.27
Previous Close$13.97
Day High$15.04
Day Low$13.73
52W High$50.40
52W Low$13.73
Volume—
Avg Volume1.11M
Market Cap444.94M
P/E Ratio—
EPS$-2.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
-1.7% upside
Current
$14.22
$14.22
Target
$13.98
$13.98
$9.74
$13.98 avg
$16.17
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 61.59M | 55.54M | 66.64M |
| Net Income | 19.38M | 14.59M | 22.25M |
| Profit Margin | 31.5% | 26.3% | 33.4% |
| EBITDA | 32.48M | 26.94M | 31.76M |
| Free Cash Flow | 24.80M | 19.95M | 25.11M |
| Rev Growth | +17.7% | +18.8% | -7.8% |
| Debt/Equity | 0.99 | 1.18 | 1.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |